SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-QSB

                                   (Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934

                For the quarterly period ended February 28, 2003

                                       OR

[ ]  TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934

          From the transition period from ___________ to ____________.

                         Commission File Number 0-29439
                                                -------


                            TWISTEE TREAT CORPORATION
                            -------------------------
        (Exact name of small business issuer as specified in its charter)

                               Delaware 43-1796315
                               -------------------
    (State or other jurisdiction of incorporation or organization)(IRS Employer
                               Identification No.)


                 710 W. 24th Street, Kansas City, Missouri 64108
                 -----------------------------------------------
                    (Address of principal executive offices)

                                  (816) 283-8446
                           ---------------------------
                           (Issuer's telephone number)

                                      N/A
   --------------------------------------------------------------------------
   (Former name, former address and former fiscal year, if changed since last
                                    report)

     Indicate by check mark whether the registrant (1) filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the past
90 days:

               Yes:  X     No:
                    ---

As of April 11, 2003 5,107,797 shares of Common Stock of the issuer were
outstanding.


<PAGE>
                            TWISTEE TREAT CORPORATION
                                  FORM 10-QSB

                                      INDEX

                                     PART I


Item 1.  Financial Statements                                               F-3

Item 2.  Management's Discussion and Analysis of Financial Condition        F-7
         and Results of Operations

                                    PART II

Item 1.  Legal Proceedings                                                  F-9

Item 6.  Exhibits and Reports on Form 8-K                                   F-10

Signatures                                                                  F-10


<PAGE>
<TABLE>
<CAPTION>
                          PART I. FINANCIAL INFORMATION


ITEM 1.  FINANCIAL STATEMENTS

                                        TWISTEE TREAT CORPORATION
                                             BALANCE SHEETS


                                                                           FEBRUARY 28,    NOVEMBER 30,
                                                                               2003            2002
                                                                          ------------------------------
                                                                           (UNAUDITED)
ASSETS
<S>                                                                       <C>             <C>
Current assets:
  Cash                                                                    $       9,579   $      15,962
                                                                          --------------  --------------
    Total current assets                                                          9,579          15,962

Property and equipment, net                                                      85,342          92,290
                                                                          --------------  --------------
                                                                          $      94,921   $     108,252
                                                                          ==============  ==============


                             LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities:
  Accounts payable                                                        $     188,121   $     195,369
  Notes payable - shareholders                                                   20,000          20,000
                                                                          --------------  --------------
    Total current liabilities                                                   208,121         215,369
                                                                          --------------  --------------

Stockholders' equity (deficit):
  Preferred stock, $.0001 par value, 10,000,000 shares authorized:
    none issued and outstanding                                                       -               -
  Common stock, $.0001 par value, 50,000,000 shares
    authorized:  4,607,797 and 3,007,795 shares issued and outstanding:             461             301
  Additional paid-in capital                                                  3,810,574       3,747,774
  Accumulated deficit                                                        (3,824,235)     (3,755,192)
                                                                          --------------  --------------
                                                                                (13,200)         (7,117)
  Less: subscriptions receivable                                               (100,000)       (100,000)
                                                                          --------------  --------------
    Total stockholders' equity (deficit)                                       (113,200)       (107,117)
                                                                          --------------  --------------
                                                                          $      94,921   $     108,252
                                                                          ==============  ==============
</TABLE>


<PAGE>
<TABLE>
<CAPTION>
                            TWISTEE TREAT CORPORATION
                            STATEMENTS OF OPERATIONS
                                   (UNAUDITED)



                                             THREE MONTHS ENDED
                                                 FEBRUARY 28,
                                             2003         2002
                                          -----------  -----------
<S>                                       <C>          <C>
Net sales                                 $        -   $        -
Cost of sales                                      -            -
                                          -----------  -----------
Gross profit (loss)                                -            -

Operating expenses:
  Payroll and contractual expense             24,855       41,666
  Depreciation and amortization expense        6,948        6,948
  Consulting expense                          34,200            -
  Legal and professional fees                      -        6,000
  Other general and administrative             3,040       10,917
                                          -----------  -----------
                                              69,043       65,531
                                          -----------  -----------

Loss from operations                         (69,043)     (65,531)

  Interest expense                                 -       (4,982)

                                          -----------  -----------
Net loss                                  $  (69,043)  $  (70,513)
                                          ===========  ===========

Basic and diluted loss per common share   $    (0.02)  $    (0.00)
                                          ===========  ===========

Weighted average shares outstanding        3,066,151    2,058,351
                                          ===========  ===========
</TABLE>


<PAGE>
<TABLE>
<CAPTION>
                              TWISTEE TREAT CORPORATION
                               STATEMENTS OF CASH FLOWS
                                     (UNAUDITED)



                                                                THREE MONTHS ENDED
                                                                    FEBRUARY 28,
                                                             ------------------------
                                                                 2003         2002
                                                             ------------------------
<S>                                                          <C>           <C>
Cash flows from operating activities:
  Net loss                                                   $   (69,043)  $ (70,513)
    Adjustments to reconcile net income to net cash
      provided by (used in) operating activities:
    Depreciation and amortization                                  6,948       6,948
  Changes in operating assets and liabilities
    Accounts payable and accrued expenses                         (7,248)    (22,607)
                                                             ------------  ----------
        Net cash provided by (used in) operating activities      (69,043)    (39,524)
                                                             ------------  ----------

Cash flows from financing activities:
  Proceeds from sale of common stock                              62,960      40,000
                                                             ------------  ----------
        Net cash provided by financing activities                 62,960      40,000
                                                             ------------  ----------

Net increase (decrease) in cash and cash equivalents              (6,383)        476
Cash and cash equivalents at beginning of period                  15,962       2,322
                                                             ------------  ----------
Cash and cash equivalents at end of period                   $     9,579   $   2,798
                                                             ============  ==========

Cash paid for:
  Interest                                                   $         -   $       -
                                                             ============  ==========
</TABLE>


<PAGE>
                            TWISTEE TREAT CORPORATION
                      NOTES TO INTERIM FINANCIAL STATEMENTS
                                FEBRUARY 28, 2003


Note 1:Presentation

The balance sheet of the Company as of February 28, 2003, the related statements
of operations for the three months ended February 28, 2003 and 2002 and the
statements of cash flows for the three months ended February 28, 2003 and 2002
included in the financial statements have been prepared by the Company without
audit.  In the opinion of management, the accompanying financial statements
include all adjustments (consisting of normal, recurring adjustments) necessary
to summarize fairly the Company's financial position and results of operations.
The results of operations for the three months ended February 28, 2003 are not
necessarily indicative of the results of operations for the full year or any
other interim period.  The information included in this Form 10-QSB should be
read in conjunction with Management's Discussion and Analysis and Financial
Statements and notes thereto included in the Twistee Treat Corporation's
November 30, 2002 Form 10-KSB.


<PAGE>
ITEM 2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS

THIS  REPORT  CONTAINS  FORWARD LOOKING STATEMENTS WITHIN THE MEANING OF SECTION
27A  OF THE SECURITIES ACT OF 1933, AS AMENDED AND SECTION 21E OF THE SECURITIES
EXCHANGE  ACT  OF  1934,  AS  AMENDED. THE COMPANY'S ACTUAL RESULTS COULD DIFFER
MATERIALLY FROM THOSE SET FORTH ON THE FORWARD LOOKING STATEMENTS AS A RESULT OF
THE  RISKS  SET  FORTH IN THE COMPANY'S FILINGS WITH THE SECURITIES AND EXCHANGE
COMMISSION,  GENERAL ECONOMIC CONDITIONS, AND CHANGES IN THE ASSUMPTIONS USED IN
MAKING  SUCH  FORWARD  LOOKING  STATEMENTS.

GENERAL OVERVIEW

Overview.

Twistee Treat operated and franchised soft-serve ice cream desserts and an
assortment of other foods and beverages in its proprietary, cone-shaped
buildings and kiosks.  Incorporated in Missouri in 1997, we redomiciled by
merger into a Delaware corporation in June of 1999 with the name Twistee Treat
Corporation.  On April 6, 2000, we purchased a publicly-reporting Nevada
corporation, Perfection Plus, Inc., as described more fully in our Form 8-K
filed with the Securities and Exchange Commission on April 8, 2000, and as
subsequently amended.  During the three months ended February 30, 2003, the
Company did not have any operations and had three inactive franchises.


RESULTS OF OPERATIONS

THREE MONTHS ENDED FEBRUARY 28, 2003 COMPARED TO THREE MONTHS ENDED FEBRUARY 28,
2002

There  were  no net sales for the three months ended February 28, 2003 and 2002,
respectively.  Twistee  is  pursuing  strategic  partners  or merger candidates.

Operating  expenses  for  the  three months ended February 28, 2003 increased by
$3,512  or  5% to $69,043 from $65,531 for the corresponding period of the prior
year.  The  increase is attributable to the Company incurring consulting fees in
reviewing  strategies  for  renewing  its  operations.

Net  loss  for the three months ended February 28, 2003 increased by $3,512 to a
loss of $69,043 from a loss of $65,531 for the corresponding period of the prior
year.  For the three months ended February 28, 2003 and 2002 the Company did not
record  a  tax  benefit.


LIQUIDITY AND CAPITAL RESOURCES

At February 28, 2003, the Company had negative working capital of $198,542.

Net  cash  provided  by  financing activities increased to $62,960 from $40,000.
The  Company  received  $62,960  from the sale of its common stock for the three
months  ended  February  28,  2003.  The  Company utilized those proceeds to pay
current  expenses.

The Company has no credit line or other bank debt, and has generated its cash
from the sale of its common stock.  At February 28, 2003, the Company had a
stockholders' deficit of $113,200, an increase of approximately 6% from the
$107,117 of stockholders' deficit existing at November 30, 2002.

As reflected in the accompanying financial statements and at February 28, 2003,
the Company has a working capital deficit of $198,542 and a net loss from
operations of $69,043 for the three months ended February 28, 2003.  The
Company's operations are not sufficient to finance its growth.  The ability of
the Company to continue as a going concern is dependent upon its ability to
raise additional capital and implement its business plan.  The Company
anticipates issuing additional debt and equity securities and reducing operating
overhead.  Management believes that actions presently taken to improve its
future operations and obtain additional funding provide the opportunity for the
Company to continue as a going concern.


<PAGE>
FACTORS THAT MAY AFFECT FUTURE RESULTS

Dependence Upon External Financing:  The Company has been building its business
through revenues generated from operations, supplemented by the sale of its
capital common stock.  The ability of the Company to continue to grow and expand
its business is highly dependent upon the ability of the Company to continue to
raise external financing, from the sale of equity and/or the incurrence of debt.
If the Company were unable to obtain debt and/or equity financing upon terms
that were sufficiently favorable to the Company, or at all, it would have a
materially adverse impact upon the ability of the Company to continue to expand
its business and operations, or to implement its business plan as now
contemplated by the Company.

Reliance on Key Management:  The success of the Company is highly dependent upon
the continued services of Steven Levin, its Chief Executive Officer and James A.
Tilton, its Chief Financial Officer, who are the primary persons responsible for
building the Company's renewed franchises, regional development and licensing
business.  If either were to leave the Company, it could have a materially
adverse effect upon the business and operations of the Company.

OTHER INFORMATION

ITEM 1: Legal Proceedings

Twistee  Treat  was  named  as  a defendant in a collections lawsuit filed by an
individual  in  the  amount of $10,000. In response, Twistee Treat filed a third
party  complaint against the individual for various fraudulent transactions. The
case  was  settled  and  Twistee  Treat  paid  $7,500.

The  Company has a dispute with a law firm regarding past due fees. The law firm
Feldhake,  August  &  Roquemore  LLP  received a default judgment for $16,349.94
composed  of  principal  and  interest  on May 28, 2002 in the Superior Court of
California,  County  of  Orange  styled  as  case  number  01HL04797.

The  Company  filed  a  lawsuit on February 5, 2003 against 3866955 Canada Inc.,
Liptok,  Inc.,  Twistee  Treat  Canada,  3585468  Canada, Inc., Andrew Evans and
Twisters  Ice Cream in the United States District Court in the Southern District
of Florida styled as cause number 03-60168. The Company is seeking a declaratory
judgment with respect to the sole and exclusive right to a trademark and service
mark  relating to a building design. Among the other causes of action brought by
the  Company  include the following: falsity and fraud in trademark application;
federal trademark infringement; trade dress infringement; unfair competition and
false  designation  of origin; common law trademark, trade name infringement and
unfair  competition;  and  domain  infringement.


<PAGE>
PART II - OTHER INFORMATION


Item 2.  Changes In Securities

During the quarter ended February 2003, Calder Investments, Ltd. acquired
2,000,000 shares of common stock for $0.03 per share.

During February 2003, Gordon Wilson, a director acquired 100,000 shares of
common stock for $0.03 per share.


Item 6.   EXHIBITS AND REPORTS ON FORM 8-K

          a)   Exhibits

          99.1  Certification of Chief Executive Officer and Chief Financial
          Officer Pursuant to 18 U.S.C. Section 1350

          b)   Reports on Form 8-K

          None



                                   SIGNATURES

In  accordance  with  the  requirements  of the Exchange Act, the Registrant has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

     . . . . . . . . . . . . . .. . . . . . . . . . . TWISTEE TREAT CORPORATION

Dated:  April 10, 2003

     . . . . . . . . . . . . . . . . . . . . . . . . . . By:  /s/  STEVEN LEVIN
     . . . . . . . . . . . . . . . . . . .Steven Levin, Chief Executive Officer

Dated:  April 10, 2003

     . . . . . . . . . . . . . . . . . . . . . . . . . By:  /s/ JAMES A. TILTON
     . . . . . . . . . . . . . . James A. Tilton (Principal Accounting Officer)


<PAGE>
CERTIFICATION


I,  Steven  Levin,  certify  that:

     I  have  reviewed  this  quarterly  report  on Form 10-QSB of Twistee Treat
Corporation;

     Based  on  my  knowledge, this quarterly report does not contain any untrue
statement  of a material fact or omit to state a material fact necessary to make
the  statements  made, in light of the circumstances under which such statements
were  made,  not misleading with respect to the period covered by this quarterly
report;

     Based  on  my  knowledge,  the  financial  statements,  and other financial
information  included  in  this quarterly report, fairly present in all material
respects  the  financial  condition, results of operations and cash flows of the
registrant  as  of,  and  for,  the  periods presented in this quarterly report;

     The  registrant's  other  certifying  officers  and  I  are responsible for
establishing  and  maintaining disclosure controls and procedures (as defined in
Exchange  Act  Rules  13a-14  and  15d-14)  for  the  registrant  and  have:

a)     designed  such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is  made  known  to  us by others within those entities, particularly during the
period  in  which  this  quarterly  report  is  being  prepared;

b)     evaluated  the  effectiveness of the registrant's disclosure controls and
procedures  as  of  a  date  within  90  days  prior  to the filing date of this
quarterly  report  (the  "Evaluation  Date");  and

c)     presented  in  this  quarterly  report  our  conclusions  about  the
effectiveness  of the disclosure controls and procedures based on our evaluation
as  of  the  Evaluation  Date;


     The  registrant's  other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
of  the  registrant's  board  of directors (or persons performing the equivalent
functions):

a)     all  significant  deficiencies  in  the  design  or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and

b)     any  fraud,  whether  or  not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and


     The  registrant's  other  certifying  officers and I have indicated in this
quarterly  report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the  date  of  our most recent evaluation, including any corrective actions with
regard  to  significant  deficiencies  and  material  weaknesses.


Date:  April 10, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     . . . . . . . . . . . . . . . . . . . . . . . . . . . . . /s/  STEVEN LEVIN
Steven Levin, Chief Executive Officer (Principal Executive Officer)


<PAGE>
CERTIFICATION


I, James A. Tilton, certify that:

     I  have  reviewed  this  quarterly  report  on Form 10-QSB of Twistee Treat
Corporation;

     Based  on  my  knowledge, this quarterly report does not contain any untrue
statement  of a material fact or omit to state a material fact necessary to make
the  statements  made, in light of the circumstances under which such statements
were  made,  not misleading with respect to the period covered by this quarterly
report;

     Based  on  my  knowledge,  the  financial  statements,  and other financial
information  included  in  this quarterly report, fairly present in all material
respects  the  financial  condition, results of operations and cash flows of the
registrant  as  of,  and  for,  the  periods presented in this quarterly report;

     The  registrant's  other  certifying  officers  and  I  are responsible for
establishing  and  maintaining disclosure controls and procedures (as defined in
Exchange  Act  Rules  13a-14  and  15d-14)  for  the  registrant  and  have:

a)     designed  such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is  made  known  to  us by others within those entities, particularly during the
period  in  which  this  quarterly  report  is  being  prepared;

b)     evaluated  the  effectiveness of the registrant's disclosure controls and
procedures  as  of  a  date  within  90  days  prior  to the filing date of this
quarterly  report  (the  "Evaluation  Date");  and

c)     presented  in  this  quarterly  report  our  conclusions  about  the
effectiveness  of the disclosure controls and procedures based on our evaluation
as  of  the  Evaluation  Date;


     The  registrant's  other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
of  the  registrant's  board  of directors (or persons performing the equivalent
functions):

a)     all  significant  deficiencies  in  the  design  or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and

b)     any  fraud,  whether  or  not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and


     The  registrant's  other  certifying  officers and I have indicated in this
quarterly  report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the  date  of  our most recent evaluation, including any corrective actions with
regard  to  significant  deficiencies  and  material  weaknesses.


Date:  April 10, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     . . . . . . . . . . . . . . . . . . . . . . . . . . /s/  JAMES  A.  TILTON
James A. Tilton, Chief Financial Officer (Principal Financial Officer)


<PAGE>